For: | Lin J, Lin ZQ, Zheng SC, Chen Y. Immune checkpoint inhibitor-associated gastritis: Patterns and management. World J Gastroenterol 2024; 30(14): 1941-1948 [PMID: 38681126 DOI: 10.3748/wjg.v30.i14.1941] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i14/1941.htm |
Number | Citing Articles |
1 |
Ying-Fang Deng, Xian-Shu Cui, Liang Wang. Reconceptualization of immune checkpoint inhibitor-associated gastritis. World Journal of Gastroenterology 2024; 30(36): 4031-4035 doi: 10.3748/wjg.v30.i36.4031
|
2 |
Bo-Tong Ma, Li-Xuan Sang, Bing Chang. Gastric microbiota transplantation as a potential treatment for immune checkpoint inhibitor-associated gastritis. World Journal of Gastroenterology 2024; 30(24): 3123-3125 doi: 10.3748/wjg.v30.i24.3123
|
3 |
Carolina Colli Cruz, Maria Julia Moura Nascimento Santos, Sharada Wali, Krishnavathana Varatharajalu, Anusha Thomas, Yinghong Wang. Gastrointestinal toxicities associated with immune checkpoint inhibitors therapy: risks and management. Immunotherapy 2025; 17(4): 293 doi: 10.1080/1750743X.2025.2473305
|
4 |
Wenqiang Tang, Yun Lv, Xiyue Yang, Kunyuan Gan, Gang Feng, Jie Li, Lu Ni, Yuxi Bai, Xiaobo Du, Feng Gao. Sintilimab‑induced acute erosive hemorrhagic gastritis as an adverse reaction of third‑line therapy in a nasopharyngeal carcinoma patient: A case report. Oncology Letters 2025; 30(1): 1 doi: 10.3892/ol.2025.15072
|
5 |
Li-Li Yu, Zhi-Lin He, Xin-Lai Qian. Managing immune checkpoint inhibitor-associated gastritis: Insights and strategies. World Journal of Gastroenterology 2024; 30(24): 3120-3122 doi: 10.3748/wjg.v30.i24.3120
|